Previous Close | 12.90 |
Open | 12.31 |
Bid | 14.29 x 1000 |
Ask | 14.44 x 600 |
Day's Range | 12.03 - 14.80 |
52 Week Range | 3.53 - 15.00 |
Volume | |
Avg. Volume | 12,564,440 |
Market Cap | 2.121B |
Beta (5Y Monthly) | 1.62 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.05 |
Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 18.00 |
Novavax, Inc (NVAX) and Fulcrum Therapeutics, Inc (FULC) are in the spotlight following license agreements with pharma giant Sanofi.
The past five days have been a rollercoaster for Novavax investors, as the share price of the company skyrocketed by over 200% following the announcement of a major deal with French pharmaceutical giant Sanofi.
GameStop, AMC, Novavax, S&P 500 Index ETF and Nvidia have been highlighted in this Investment Ideas article.